These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16575401)
1. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Leung SY; Ho C; Tu IP; Li R; So S; Chu KM; Yuen ST; Chen X Mod Pathol; 2006 Jun; 19(6):854-63. PubMed ID: 16575401 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the 19q12 amplicon in grade III breast cancers. Natrajan R; Mackay A; Wilkerson PM; Lambros MB; Wetterskog D; Arnedos M; Shiu KK; Geyer FC; Langerød A; Kreike B; Reyal F; Horlings HM; van de Vijver MJ; Palacios J; Weigelt B; Reis-Filho JS Breast Cancer Res; 2012 Mar; 14(2):R53. PubMed ID: 22433433 [TBL] [Abstract][Full Text] [Related]
4. Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer. Etemadmoghadam D; George J; Cowin PA; Cullinane C; Kansara M; ; Gorringe KL; Smyth GK; Bowtell DD PLoS One; 2010 Nov; 5(11):e15498. PubMed ID: 21103391 [TBL] [Abstract][Full Text] [Related]
5. Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. Noske A; Brandt S; Valtcheva N; Wagner U; Zhong Q; Bellini E; Fink D; Obermann EC; Moch H; Wild PJ Oncotarget; 2017 Feb; 8(9):14794-14805. PubMed ID: 27582547 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes. Noske A; Henricksen LA; LaFleur B; Zimmermann AK; Tubbs A; Singh S; Storz M; Fink D; Moch H Exp Mol Pathol; 2015 Feb; 98(1):47-54. PubMed ID: 25527175 [TBL] [Abstract][Full Text] [Related]
7. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121 [TBL] [Abstract][Full Text] [Related]
8. 19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomes. Aziz D; Etemadmoghadam D; Caldon CE; Au-Yeung G; Deng N; Hutchinson R; ; Bowtell D; Waring P Gynecol Oncol; 2018 Nov; 151(2):327-336. PubMed ID: 30209015 [TBL] [Abstract][Full Text] [Related]
9. Identification of Calcagno DQ; Takeno SS; Gigek CO; Leal MF; Wisnieski F; Chen ES; Araújo TM; Lima EM; Melaragno MI; Demachki S; Assumpção PP; Burbano RR; Smith MC World J Gastroenterol; 2016 Nov; 22(43):9506-9514. PubMed ID: 27920471 [TBL] [Abstract][Full Text] [Related]
10. CCNE1 amplification is associated with liver metastasis in gastric carcinoma. Kim B; Shin HC; Heo YJ; Ha SY; Jang KT; Kim ST; Kang WK; Lee J; Kim KM Pathol Res Pract; 2019 Aug; 215(8):152434. PubMed ID: 31178228 [TBL] [Abstract][Full Text] [Related]
11. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Hou Q; Wu YH; Grabsch H; Zhu Y; Leong SH; Ganesan K; Cross D; Tan LK; Tao J; Gopalakrishnan V; Tang BL; Kon OL; Tan P Cancer Res; 2008 Jun; 68(12):4623-30. PubMed ID: 18559507 [TBL] [Abstract][Full Text] [Related]
12. Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma. Goundiam O; Gestraud P; Popova T; De la Motte Rouge T; Fourchotte V; Gentien D; Hupé P; Becette V; Houdayer C; Roman-Roman S; Stern MH; Sastre-Garau X Int J Cancer; 2015 Oct; 137(8):1890-900. PubMed ID: 25892415 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin. Zhang C; Zhu Q; Gu J; Chen S; Li Q; Ying L Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072916 [TBL] [Abstract][Full Text] [Related]
14. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Myllykangas S; Junnila S; Kokkola A; Autio R; Scheinin I; Kiviluoto T; Karjalainen-Lindsberg ML; Hollmén J; Knuutila S; Puolakkainen P; Monni O Int J Cancer; 2008 Aug; 123(4):817-25. PubMed ID: 18506690 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1. Zhang Z; Shen M; Zhou G Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043 [TBL] [Abstract][Full Text] [Related]